These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
460 related items for PubMed ID: 24556822
1. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases. Sagi L, Zvulunov A, Lapidoth M, Ben Amitai D. Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822 [Abstract] [Full Text] [Related]
3. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic. Bertrand J, Sammour R, McCuaig C, Dubois J, Hatami A, Ondrejchak S, Boutin C, Bortoluzzi P, Laberge LC, Powell J. J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306 [Abstract] [Full Text] [Related]
4. The use of propranolol for complicated infantile hemangiomas. Vercellino N, Romanini MV, Pelegrini M, Rimini A, Occella C, Dalmonte P. Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783 [Abstract] [Full Text] [Related]
6. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature. Broeks IJ, Hermans DJ, Dassel AC, van der Vleuten CJ, van Beynum IM. Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695 [Abstract] [Full Text] [Related]
12. Late rebound of infantile hemangioma after cessation of oral propranolol. Shehata N, Powell J, Dubois J, Hatami A, Rousseau E, Ondrejchak S, McCuaig C. Pediatr Dermatol; 2013 Nov; 30(5):587-91. PubMed ID: 24016283 [Abstract] [Full Text] [Related]
13. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients. Stringari G, Barbato G, Zanzucchi M, Marchesi M, Cerasoli G, Tchana B, Gritti A, Boccaletti V, Lombardi AA, Carano N. Pediatr Med Chir; 2016 Jun 27; 38(2):113. PubMed ID: 27345601 [Abstract] [Full Text] [Related]
16. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study. Yu Z, Cai R, Chang L, Qiu Y, Chen X, Chen Q, Ma G, Jin Y, Lin X. J Dermatol; 2019 May 27; 46(5):376-382. PubMed ID: 30916822 [Abstract] [Full Text] [Related]
17. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study. Greco A, D'Erme AM, Zamma Gallarati B, Caputo R, de Martino M. Dermatol Ther; 2014 May 27; 27(4):198-202. PubMed ID: 24548454 [Abstract] [Full Text] [Related]
18. Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience. El Hachem M, Gesualdo F, Diociaiuti A, Berti I, Vercellino N, Boccaletti V, Neri I, Porcedda G, Greco A, Carnevale C, Oranges T, Cutrone M, Dalmonte P. Ital J Pediatr; 2017 Apr 19; 43(1):40. PubMed ID: 28424095 [Abstract] [Full Text] [Related]
19. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study. Betlloch-Mas I, Martínez-Miravete MT, Lucas-Costa A, Martin de Lara AI, Selva-Otalaurruchi J. Actas Dermosifiliogr; 2012 Nov 19; 103(9):806-15. PubMed ID: 22727954 [Abstract] [Full Text] [Related]
20. Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol. Ahogo CK, Ezzedine K, Prey S, Colona V, Diallo A, Boralevi F, Taïeb A, Léauté-Labrèze C. Br J Dermatol; 2013 Dec 19; 169(6):1252-6. PubMed ID: 23662995 [Abstract] [Full Text] [Related] Page: [Next] [New Search]